Not yet recruitingNCT06651112

The ATP Project (Antipsychotic-TEP-Psychosis)

Studying Other metabolic disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Université de Sherbrooke
Principal Investigator: Stephen Cunnane, Ph.D
Université de Sherbrooke
Intervention: Antipsychotic drugs(drug)
Enrollment: 18 target
Eligibility: 18-35 years · All sexes
Timeline: 2024 – 2027

Study locations (1)

Hotel-Dieu CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada

Collaborators

Baszucki Brain Research Fund

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06651112 on ClinicalTrials.gov

← Back to all trials